🔗 Visit the ClinicalTrials.gov page for NCT01231685
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials. | Lancet | 2010 | 2.63 |
| 2 | Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C. | J Antimicrob Chemother | 2009 | 1.01 |